癌胚抗原、细胞角蛋白19片段、神经元特异性烯醇化酶及癌抗原125检测在肺癌患者血清及胸腔积液中的诊断价值 - Suppr

Suppr

超能文献

Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer.

作者信息

Wu Guang-Ping, Ba Jing, Zhao Yu-Jie, Wang En-Hua

出版信息

Acta Cytol. 2007 Jul-Aug;51(4):679-80.

PMID:17718156

Abstract

摘要

相似文献

Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer.

Acta Cytol. 2007 Jul-Aug;51(4):679-80.

Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.

Chest. 2005 Oct;128(4):2298-303. doi: 10.1378/chest.128.4.2298.

Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.

Anticancer Res. 2001 Jul-Aug;21(4B):3085-92.

[Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy].

Nihon Kokyuki Gakkai Zasshi. 2002 Feb;40(2):106-12.

Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.

Anticancer Res. 2005 May-Jun;25(3A):1773-8.

Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE.

Anticancer Res. 1997 Jul-Aug;17(4B):2875-8.

[Clinical evaluation of various tumor markers in pleural effusion and in the serum].

Gan No Rinsho. 1989 Aug;35(9):991-8.

[Diagnostic value of the tumor markers TPA-M, CYPFRA 21-1 and CEA in pleural effusion. Prospective comparison of thoracoscopic investigations in patients with pleural effusion].

Pneumologie. 1999 Oct;53(10):471-6. doi: 10.1055/s-1999-9039.

[Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma].

Pneumologia. 2008 Jul-Sep;57(3):175-7.

[Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Sep;39(5):832-5.

引用本文的文献

Machine learning applied to near-infrared spectra for clinical pleural effusion classification.

Sci Rep. 2021 May 3;11(1):9411. doi: 10.1038/s41598-021-87736-4.

Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.

BMC Cancer. 2017 Aug 30;17(1):590. doi: 10.1186/s12885-017-3572-2.

Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion.

Chin Med J (Engl). 2016 Feb 5;129(3):253-8. doi: 10.4103/0366-6999.174501.

Diagnostic values of vascular endothelial growth factor and epidermal growth factor receptor for benign and malignant hydrothorax.

Chin Med J (Engl). 2015 Feb 5;128(3):305-9. doi: 10.4103/0366-6999.150091.

Combining multiple serum biomarkers in tumor diagnosis: A clinical assessment.

Mol Clin Oncol. 2013 Jan;1(1):153-160. doi: 10.3892/mco.2012.23. Epub 2012 Sep 19.

Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma.

Tumour Biol. 2012 Dec;33(6):2209-16. doi: 10.1007/s13277-012-0482-4. Epub 2012 Aug 14.

[Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion].

Zhongguo Fei Ai Za Zhi. 2010 Jun;13(6):652-4. doi: 10.3779/j.issn.1009-3419.2010.06.017.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验